Deficiency of Alveolar Epithelial FADS2 Contributes to Pulmonary Fibrosis
Xinzhi Liang(Brigham and Women's Hospital), Iván O. Rosas(Brigham and Women's Hospital), Rachel S. Kelly(Imperial College London), Souheil El‐Chemaly(AVEO Oncology (United States)), Konstantin Tsoyi(University of Maryland, Baltimore), Yuichi Sakairi(Brigham and Women's Hospital), Dawn L. DeMeo(Brigham and Women's Hospital), E. Kim(Brigham and Women's Hospital), Benjamin A. Raby(Brigham and Women's Hospital), Mark A. Perrella(Brigham and Women's Hospital), George R. Washko(Brigham and Women's Hospital), R. Chase, Gary M. Hunninghake(Hubei University of Science and Technology), Sarah Chu(Brigham and Women's Hospital), Y.-D. Li(Beijing University of Chinese Medicine)
Cited by 0
Related Papers
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
|Proceedings of the National Academy of Sciences|1994|806
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
|Circulation Research|1993|776
Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP.
|Proceedings of the National Academy of Sciences|1995|710